Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bone Density Conservation Agents therapeutic use"" wg kryterium: Temat


Tytuł:
Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia: A 6-Year Prospective Cohort Study
Autorzy:
Signe Sparre Beck-Nielsen
Niklas Rye Jørgensen
Vikram Vinod Shanbhogue
Stinus Hansen
Pokaż więcej
Temat:
Endocrinology
Orthopedics and Sports Medicine
Endocrinology, Diabetes and Metabolism
Bone remodeling
Medicine
business.industry
business
Urology
medicine.medical_specialty
Bone density
Internal medicine
Osteomalacia
medicine.disease
X-linked hypophosphatemia
Rickets
Hypophosphatemia
Alfacalcidol
chemistry.chemical_compound
chemistry
Bone mineral
BMD
Bone markers
Bone turnover
Conventional medical therapy
Adolescent
Adult
Aged
Bone Density Conservation Agents/therapeutic use
Bone Density/drug effects
Bone Remodeling/drug effects
Familial Hypophosphatemic Rickets/drug therapy
Female
Fibroblast Growth Factors/metabolism
Humans
Lumbar Vertebrae/drug effects
Male
Middle Aged
Prospective Studies
Young Adult
musculoskeletal diseases
Źródło:
Shanbhogue, V V, Hansen, S, Jørgensen, N R & Beck-Nielsen, S S 2018, ' Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia : A 6-Year Prospective Cohort Study ', Calcified Tissue International, vol. 102, no. 3, pp. 321-328 . https://doi.org/10.1007/s00223-017-0363-3
Shanbhogue, V V, Hansen, S, Jørgensen, N R & Beck-Nielsen, S S 2018, ' Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia : A 6-Year Prospective Cohort Study ', Calcified Tissue International, vol. 102, no. 3, pp. 321–328 . https://doi.org/10.1007/s00223-017-0363-3
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d02db08b30aa02014bd741ada933d88
http://link.springer.com/article/10.1007/s00223-017-0363-3/fulltext.html
Tytuł:
The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study):a randomized controlled trial
Autorzy:
Jepsen, D. B.
Ryg, J.
Hansen, S.
Jørgensen, N. R.
Gram, J.
Masud, T.
Pokaż więcej
Temat:
postmenopausal osteoporosis
randomized controlled trial
teriparatide
whole-body vibration
Endocrinology, Diabetes and Metabolism
Randomized controlled trial
law.invention
law
Parathyroid hormone
Bone mineral
Urology
medicine.medical_specialty
medicine
Osteoporosis
medicine.disease
Bone remodeling
business.industry
business
Teriparatide
medicine.drug
Animal data
Sclerostin
chemistry.chemical_compound
chemistry
Original Article
Absorptiometry, Photon/methods
Aged
Aged, 80 and over
Biomarkers/blood
Bone Density/physiology
Bone Density Conservation Agents/therapeutic use
Bone Remodeling/physiology
Combined Modality Therapy
Exercise Therapy/methods
Female
Hip Joint/physiopathology
Humans
Lumbar Vertebrae/physiopathology
Medication Adherence/statistics & numerical data
Middle Aged
Osteoporosis, Postmenopausal/physiopathology
Teriparatide/therapeutic use
Tomography, X-Ray Computed/methods
Vibration
Journal Article
Multicenter Study
Źródło:
Jepsen, D B, Ryg, J, Hansen, S, Jørgensen, N R, Gram, J & Masud, T 2019, ' The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study) : a randomized controlled trial ', Osteoporosis International, vol. 30, no. 9, pp. 1827-1836 . https://doi.org/10.1007/s00198-019-05029-z
Osteoporosis International
Jepsen, D B, Ryg, J, Hansen, S, Jørgensen, N R, Gram, J & Masud, T 2019, ' The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study) : a randomized controlled trial ', Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 30, no. 9, pp. 1827-1836 . https://doi.org/10.1007/s00198-019-05029-z
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b015cca100931cfe79a2d4f8c26620
https://findresearcher.sdu.dk:8443/ws/files/153547185/The_combined_effect_of_Parathyroid_hormone_1_34_and_whole_body_Vibration_exercise_in_the_treatment_of_postmenopausal_OSteoporosis_PaVOS_study_.pdf
Tytuł:
Craniofacial and dental characteristics of patients with vitamin-D-dependent rickets type 1A compared to controls and patients with X-linked hypophosphatemia
Autorzy:
Signe Sparre Beck-Nielsen
Dorte Haubek
Hans Gjørup
Pokaż więcej
Temat:
General Dentistry
Vitamin
chemistry.chemical_compound
chemistry
Internal medicine
medicine.medical_specialty
medicine
business.industry
business
Rickets
medicine.disease
X-linked hypophosphatemia
Case-control study
In patient
Vitamin D-dependent rickets
Craniofacial
Endocrinology
Hypophosphatemia
Cephalometry
Craniofacial morphology
Enamel
Vitamin-D-dependent rickets type 1A
ENAMEL HYPOPLASIA
APPEARANCE
PRIMARY TEETH
DISORDERS
D-RESISTANT RICKETS
DEFICIENCY
DELETION SYNDROME
D-3 1-ALPHA-HYDROXYLASE GENE
BONE
MUTATIONS
Humans
Infant
Male
Bone Density Conservation Agents/therapeutic use
Case-Control Studies
Hydroxycholecalciferols/therapeutic use
Female
Registries
Familial Hypophosphatemic Rickets/drug therapy
Phenotype
Denmark
Skull/abnormalities
Tooth Abnormalities/pathology
Journal Article
stomatognathic diseases
stomatognathic system
Źródło:
Gjørup, H, Beck-Nielsen, S S & Haubek, D 2018, ' Craniofacial and dental characteristics of patients with vitamin-D-dependent rickets type 1A compared to controls and patients with X-linked hypophosphatemia ', Clinical Oral Investigations, vol. 22, no. 2, pp. 745-755 . https://doi.org/10.1007/s00784-017-2149-4
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85610022b45b7641e87c8e7c158f7610
http://link.springer.com/article/10.1007/s00784-017-2149-4/fulltext.html
Tytuł:
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis
Autorzy:
Thierry Thomas
Dieter Felsenberg
René Rizzoli
Isolde Frieling
Michel Laroche
Pierre D. Delmas
Marc-Antoine Krieg
Pokaż więcej
Temat:
quantitative computed-tomography
trabecular bone
postmenopausal osteoporosis
mineral density
mechanisms
strength
fractures
risk
microarchitecture
bisphosphonates
ddc:618.97
Alendronate/*therapeutic use
Bone Density/drug effects
Bone Density Conservation Agents/*therapeutic use
Female
Femur Neck/drug effects/metabolism/radiography
Fractures, Bone/prevention & control
Hip Joint/drug effects/metabolism/radiography
Humans
Middle Aged
Organometallic Compounds/*therapeutic use
Osteogenesis/drug effects/physiology
Osteoporosis, Postmenopausal/*drug therapy/metabolism/pathology
Spine/drug effects/metabolism/radiography
Thiophenes/*therapeutic use
Tibia/*drug effects/pathology
Tomography, X-Ray Computed
Original Article
Biochemical markers
Bone mineral density
Cortical bone
Microstructure
Trabecular bone
Immunology
Immunology and Allergy
Rheumatology
Strontium ranelate
medicine.drug
medicine
Bone Density Conservation Agents
medicine.anatomical_structure
Dentistry
business.industry
business
Tibia
Bone remodeling
Bone mineral
Osteoporosis
medicine.disease
Urology
medicine.medical_specialty
Bone density
musculoskeletal diseases
Źródło:
Rheumatology International, vol. 30, no. 10, pp. 1341-1348
Rheumatology International, Vol. 30, No 10 (2010) pp. 1341-1348
Rheumatology International
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce6741c9fc03e459edd42110ac3e6792
http://doc.rero.ch/record/317339/files/296_2010_Article_1542.pdf
Tytuł:
Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab:a case report
Autorzy:
Byberg, Sarah
Abrahamsen, Bo
Kassem, Moustapha
Ralston, Stuart
Schwarz, Peter
Pokaż więcej
Temat:
Journal Article
General Medicine
After treatment
Surgical oncology
Radiology
medicine.medical_specialty
medicine
Bone remodeling
Denosumab
medicine.drug
business.industry
business
Melorheostosis
medicine.disease
Radiography
Young adult
Zoledronic acid
Case Report
lcsh:Medicine
lcsh:R
Case report
Young Adult
Recurrence
Denosumab/therapeutic use
Humans
Female
Tomography, X-Ray Computed
Bone Density Conservation Agents/therapeutic use
Melorheostosis/diagnostic imaging
Źródło:
Byberg, S, Abrahamsen, B, Kassem, M, Ralston, S & Schwarz, P 2018, ' Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab : a case report ', Journal of Medical Case Reports, vol. 12, 278, pp. 1-6 . https://doi.org/10.1186/s13256-018-1820-y
Journal of Medical Case Reports
Journal of Medical Case Reports, Vol 12, Iss 1, Pp 1-6 (2018)
Byberg, S, Abrahamsen, B, Kassem, M, Ralston, S & Schwarz, P 2018, ' Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report ', Journal of Medical Case Reports, vol. 12, no. 1 . https://doi.org/10.1186/s13256-018-1820-y
Byberg, S, Abrahamsen, B, Kassem, M, Ralston, S & Schwarz, P 2018, ' Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab : a case report ', Journal of Medical Case Reports, vol. 12, 278 . https://doi.org/10.1186/s13256-018-1820-y
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34fce108ab3991ed8908c4512a79cb66
https://curis.ku.dk/ws/files/216975224/Clinical_improvement.pdf
Tytuł:
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO
Autorzy:
Diana Frey
Christian Meier
Brigitte Florence Uebelhart
Bérengère Aubry-Rozier
Kurt Lippuner
Olivier Lamy
Heike A. Bischoff-Ferrari
Norbert Suhm
Petra Stute
Serge Ferrari
Martin Birkhäuser
Reto W. Kressig
Pokaż więcej
Temat:
Antibodies, Monoclonal, Humanized/therapeutic use
Bone Density Conservation Agents/therapeutic use
Denosumab/therapeutic use
Diphosphonates/therapeutic use
Evidence-Based Practice
Female
Humans
Osteoporosis/drug therapy
Osteoporotic Fractures/prevention & control
Risk Factors
Time Factors
Rheumatology Clinic and Institute of Physical Medicine
Clinic for Geriatric Medicine
610 Medicine & health
General Medicine
Position statement
Discontinuation
Medicine
business.industry
business
Drug discontinuation
Bisphosphonate
medicine.medical_treatment
Osteoporosis
medicine.disease
Drug treatment
Denosumab
medicine.drug
Intensive care medicine
medicine.medical_specialty
High fracture
ddc:616
Źródło:
Swiss medical weekly, vol. 147, pp. w14484
Meier, Christian; Uebelhart, Brigitte; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike A; Frey, Diana; Kressig, Reto W; Lamy, Olivier; Lippuner, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss Medical Weekly, 147:w14484.
Meier, Christian; Uebelhart, Brigitte; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike A; Frey, Diana; Kressig, Reto W; Lamy, Olivier; Lippuner, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss medical weekly, 147(w14484), w14484. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14484 <http://dx.doi.org/10.4414/smw.2017.14484>
Swiss Medical Weekly, Vol. 147, No w14484 (2017)
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8193777126a13b4b9c2d0ed00ad0ef
https://serval.unil.ch/notice/serval:BIB_2F7530178F85
Tytuł:
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
Autorzy:
Kanis, J. A.
Cooper, C.
Rizzoli, R.
Abrahamsen, B.
Al-Daghri, N. M.
Brandi, M. L.
Cannata-Andia, J.
Cortet, B.
Dimai, H. P.
Ferrari, S.
Hadji, P.
Harvey, N. C.
Kraenzlin, M.
Kurth, A.
McCloskey, E.
Minisola, S.
Thomas, T.
Reginster, J.-Y.
for the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Pokaż więcej
Temat:
Endocrinology, Diabetes and Metabolism
Health care
business.industry
business
Osteoporotic fracture
Increased risk
Expert consensus
Secondary prevention
Fracture risk
Medicine
Physical therapy
medicine.medical_specialty
Intensive care medicine
Osteoporosis
medicine.disease
Healthcare burden
Management
Treatment gap
ddc:616
Humans
Risk Factors
Bone Density Conservation Agents/therapeutic use
Osteoporosis/diagnosis
Drug Utilization/statistics & numerical data
Spinal Fractures/epidemiology
Incidence
Europe/epidemiology
Risk Assessment/methods
Osteoporotic Fractures/epidemiology
Review
Źródło:
Osteoporosis International, Vol. 28, No 7 (2017) pp. 2023-2034
Kanis, J A, Cooper, C, Rizzoli, R, Abrahamsen, B, Al-Daghri, N M, Brandi, M L, Cannata-Andia, J, Cortet, B, Dimai, H P, Ferrari, S, Hadji, P, Harvey, N C, Kraenzlin, M, Kurth, A, McCloskey, E V, Minisola, S, Thomas, T, Reginster, J-Y & For The European Society For Clinical And Economic Aspects Of Osteoporosis, Osteoarthritis And Musculoskeletal Diseases (Esceo) 2017, ' Identification and management of patients at increased risk of osteoporotic fracture : outcomes of an ESCEO expert consensus meeting ', Osteoporosis International, vol. 28, no. 7, pp. 2023–2034 . https://doi.org/10.1007/s00198-017-4009-0
Osteoporosis International
Opis pliku:
application/pdf; text
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5fc13f9ad36dbb4b3fb15e6531bc84d
Tytuł:
Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer
Autorzy:
Claus Kamby
Simon Tarp
Anders Mellemgaard
Robin Christensen
Søren Cold
Pia Eiken
Erik Hugger Jakobsen
Niels Christian Langkilde
Sven Tyge Langkjer
Torben Laursen
Svend Saalbach Ottesen
Anita Gorm Pedersen
Lars Eric Stenbygaard
Peter Michael Vestlev
Pokaż więcej
Temat:
Bone Density Conservation Agents/therapeutic use
Bone Neoplasms/complications
Breast Neoplasms/pathology
Denosumab/therapeutic use
Diphosphonates/therapeutic use
Female
Humans
Lung Neoplasms/pathology
Male
Meta-Analysis as Topic
Prostatic Neoplasms/pathology
Radiography
Źródło:
Kamby, C, Tarp, S, Mellemgaard, A, Christensen, R, Cold, S, Eiken, P, Jakobsen, E H, Langkilde, N C, Langkjer, S T, Laursen, T, Ottesen, S S, Pedersen, A G, Stenbygaard, L E & Vestlev, P M 2014, ' Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer ', Ugeskrift for Laeger, bind 176, nr. 7, V08130525, s. 645-648 .
Kamby, C, Tarp, S, Mellemgaard, A, Christensen, R, Cold, S, Eiken, P, Jakobsen, E H, Langkilde, N-C, Langkjer, S T, Laursen, T, Ottesen, S S, Pedersen, A G, Stenbygaard, L & Vestlev, P M 2014, ' Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer ', Ugeskrift for Laeger, bind 176, V08130525 . < http://ugeskriftet.dk/videnskab/forebyggelse-af-skeletrelaterede-haendelser-hos-patienter-med-knoglemetastaser-ved-solide >
University of Southern Denmark
Kamby, C, Tarp, S, Mellemgaard, A, Christensen, R, Cold, S, Eiken, P, Jakobsen, E H, Langkilde, N-C, Langkjer, S T, Ottesen, S S, Laursen, T, Pedersen, A G, Stenbygaard, L E & Vestlev, P M 2014, ' Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer ', Ugeskrift for Laeger, bind 2014;176:V08130525 . < http://ugeskriftet.dk/files/ugeskriftet.dk/artikel_7143.pdf >
Dostępność:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6eee32a18cc3f919ac4fa980099ddf3b
https://portal.findresearcher.sdu.dk/da/publications/a38246a5-a85a-43df-8479-9f3918acf98e
Tytuł:
Periarticular and generalised bone loss in patients with early rheumatoid arthritis:influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial
Autorzy:
Tine Lottenburger
Merete Lund Hetland
I Hansen
Hanne Merete Lindegaard
Mikkel Østergaard
Anders Jørgen Svendsen
Jan Pødenphant
Anne Grethe Jurik
Lars Hyldstrup
Bo Zerahn
Trine W. Jensen
Peter Junker
Torkell Ellingsen
Bo Abrahamsen
Henrik Skjødt
Michael Sejer Hansen
Jens Kristian Pedersen
U.B. Lauridsen
K Stengaard-Petersen
Aage Vestergaard
L S Andersen
Kim Hørslev-Petersen
Bente L. Langdahl
Ulrik Tarp
Pokaż więcej
Temat:
Adult
Aged
Alendronate/therapeutic use
Antirheumatic Agents/therapeutic use
Arthritis, Rheumatoid/drug therapy
Betamethasone/administration & dosage
Bone Density
Bone Density Conservation Agents/therapeutic use
Bone Diseases, Metabolic/drug therapy
Bone Resorption/prevention & control
Cyclosporine/therapeutic use
Disease Progression
Double-Blind Method
Drug Therapy, Combination
Female
Glucocorticoids/administration & dosage
Humans
Injections, Intra-Articular
Lumbar Vertebrae/diagnostic imaging
Male
Methotrexate/therapeutic use
Middle Aged
Radiography
Treatment Outcome
Young Adult
General Biochemistry, Genetics and Molecular Biology
Immunology
Immunology and Allergy
Rheumatology
Medicine
business.industry
business
Methotrexate
medicine.drug
Lumbar
Bone density
Surgery
medicine.medical_specialty
Bone mineral
Rheumatoid arthritis
medicine.disease
Betamethasone
Femoral neck
medicine.anatomical_structure
Osteoporosis
musculoskeletal diseases
musculoskeletal system
Źródło:
Jensen, T W, Hansen, M S, Hørslev-Petersen, K, Hyldstrup, L, Abrahamsen, B, Langdahl, B L, Zerahn, B, Pødenphant, J, Stengaard-Petersen, K, Junker, P, Ostergaard, M, Lottenburger, T, Ellingsen, T, Andersen, L S, Hansen, I, Skjødt, H, Pedersen, J K, Lauridsen, U B, Svendsen, A J, Tarp, U, Lindegaard, H, Jurik, A G, Vestergaard, A, Hetland, M L & the Cimestra study group 2014, ' Periarticular and generalised bone loss in patients with early rheumatoid arthritis : influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial ', Annals of the Rheumatic Diseases, vol. 73, no. 6, pp. 1123-1129 . https://doi.org/10.1136/annrheumdis-2012-203171
Jensen, T W, Hansen, M S, Hørslev-Petersen, K, Hyldstrup, L, Abrahamsen, B, Langdahl, B L, Zerahn, B, Pødenphant, J, Stengaard-Pedersen, K, Junker, P, Ostergaard, M, Lottenburger, T, Ellingsen, T, Andersen, L S, Hansen, I T, Skjødt, H, Pedersen, J K, Lauridsen, U B, Svendsen, A J, Tarp, U, Lindegaard, H, Jurik, A G, Vestergaard, A, Hetland, M L & the CIMESTRA study group 2014, ' Periarticular and generalised bone loss in patients with early rheumatoid arthritis : influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial ', Annals of the Rheumatic Diseases, vol. 73, no. 6, pp. 1123-1129 . https://doi.org/10.1136/annrheumdis-2012-203171
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9bd21ebdfd283d027631ba14d1f3d42
https://portal.findresearcher.sdu.dk/da/publications/25b0d925-60ee-4fcd-b9d9-857ca21d96f5

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz